在一份回应尼森和格雷厄姆论文的声明里，葛兰素史克公司认为，2007年已经完成的所有六个临床试验结果并没有显示该药增加心脏病发作、中风或死亡风险。

In a statement issued in response to both Nissen's and Graham's papers, GSK maintains that six clinical trials completed since 2007, taken together, show no increase in heart attack, stroke or death.

youdao

在一份回应尼森和格雷厄姆论文的声明里，葛兰素史克公司认为，2007年已经完成的所有六个临床试验结果并没有显示该药增加心脏病发作、中风或死亡风险。

In a statement issued in response to both Nissen's and Graham's papers, GSK maintains that six clinical trials completed since 2007, taken together, show no increase in heart attack, stroke or death.

youdao